Víctor Manuel
Sánchez Merino
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (8)
2018
2017
-
Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 13, Núm. 2, pp. 601-609
2016
-
Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor
Biochimica et Biophysica Acta - General Subjects, Vol. 1860, Núm. 6, pp. 1139-1148
2014
-
HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds
Current Medicinal Chemistry, Vol. 21, Núm. 2, pp. 238-250
2013
-
Evolution of broadly cross-reactive HIV-1-neutralizing activity: Therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulations
Journal of Virology, Vol. 87, Núm. 22, pp. 12227-12236
-
Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions
Journal of Translational Medicine, Vol. 11, Núm. 1
-
Influenza, but not HIV-specific CTL epitopes, elicits delayed-type hypersensitivity (DTH) reactions in HIV-infected patients
European Journal of Immunology, Vol. 43, Núm. 6, pp. 1545-1554
2011
-
Definition of the viral targets of protective HIV-1-specific T cell responses
Journal of Translational Medicine, Vol. 9, Núm. 1